1Naess I A, Christiansen S C, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study [J]. J Thromb Haemost,2007,5(4):692-699. 被引量：1
3Bezemer I D, Bare L A, Doggen C J, et al. Gene variants associated with deep vein thrombosis[J]. JAMA, 2008, 299 (11): 1306-1314. 被引量：1
4McColl M, Tait R C, Walker I D, et al. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation[J]. Blood Coagul Fibrinolysis, 1996,7 (7) : 689-694. 被引量：1
6Vossen C Y, Conard J, Fontcuberta J, et al. Familial thrombophilia and lifetime risk of venous thrombosis [J]. J Thromb Haemost, 2004,2(9) : 1526-1532. 被引量：1
7Dahm A, van Hylckama Vlieg A, Bendz B, et al. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis[J]. Blood, 2003,101 ( 11 ) : 4387-4392. 被引量：1
8Uitte de Willige S, van Marion V, Rosendaal F R, et al. Haplotypes of the EPCR gene, plasmas EPCR levels and the risk of deep venous thrombosis[J]. J Thromb Haemost,2004,2(8) : 1305-1310. 被引量：1
9van Hylckama Vlieg A, Montes R, Rosendaal F R, et al. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis[J]. J Thromb Haemost, 2007,5 (7): 1449-1454. 被引量：1
10Rosendaal F R, Koster T, Vandenbroucke J P, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [J]. Blood, 1995,85 (6) : 1504- 1508. 被引量：1
5Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism[J]. Eur Heart J,2000, 21(16): 1301- 1336. 被引量：1
6Zagorski J, Sanapareddy N, Gellar M A, et al. Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats[J]. Physiol Genomics,2008,34(1) :101-111. 被引量：1
7Cohen A T, Agnelli G, Anderson F A, et al. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality[J]. Thromb Haemost, 2007,98(4) :756-764. 被引量：1
8Gale A J, Griffin J H. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va[J]. Proteins,2004,54(3):433-441. 被引量：1
9Kamphuisen P W, Eikenboom J C, Rosendaal F R, et al. High factor Ⅷ antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor Ⅷ gene[J]. Br J Haematol, 2001,115(1): 156- 158. 被引量：1
10Miyata T, Kimura R, Kokubo Y, et al. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation [J]. Int J Hematol,2006,83(3) :217-223. 被引量：1
7Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmona- ry embolism [J]. Chest, 2006, 130 (1) : 172-175. 被引量：1
8Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic throm- bcembolic pulmonary hypertension after pulmonary embolism [ J ]. N Engl J Med, 2004, 350 (22): 2257-2264. 被引量：1
9Bonderman D, Tureeek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor r in chronic thromboembolie pulmonary hyper- temion [J]. Thromb Haemost, 2003, 90 (3): 372-376. 被引量：1
